Revenue: The sum of all revenue fields included for a company's operating activities.
Collegium Pharmaceutical, Inc. (COLL) had Revenue of $193.52M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$193.52M |
$14.50M |
|
$76.27M |
|
$117.25M |
|
$162.62M |
|
$30.90M |
|
$-12.16M |
|
$18.74M |
|
$18.74M |
|
$14.50M |
|
$14.50M |
|
$14.50M |
|
$14.50M |
|
$30.90M |
|
$86.65M |
|
32.09M |
|
40.07M |
|
$0.45 |
|
$0.40 |
|
| Balance Sheet Financials | |
$745.67M |
|
$11.66M |
|
$906.29M |
|
$1.65B |
|
$434.97M |
|
$770.20M |
|
$904.56M |
|
$1.34B |
|
$312.42M |
|
$-447.54M |
|
$312.42M |
|
32.41M |
|
| Cash Flow Statement Financials | |
$57.11M |
|
$1.63M |
|
$-21.34M |
|
$252.16M |
|
$289.56M |
|
$37.40M |
|
$10.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.71 |
|
-- |
|
-- |
|
0.71 |
|
2.57 |
|
60.59% |
|
15.97% |
|
15.97% |
|
-- |
|
9.68% |
|
7.49% |
|
$56.84M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.78 |
|
0.85 |
|
106.39 |
|
4.64% |
|
-3.24% |
|
0.88% |
|
1.34% |
|
$9.64 |
|
$1.42 |
|
$1.43 |
|